Insmed (INSM) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $98.61 +2.93%
EPS Growth %: +52.9%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +52.9%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.74), $0.03 worse than the analyst estimate of ($0.71). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $34.8 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Sun Communities names Ileana McAlary as general counsel and EVP
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
